CYCLERION THERAPEUTICS CYCN 深 沪
等待开盘 07-03 09:30:00 美东时间
3.43
+0.060
+1.78%
华盛通- 最 高3.5699
- 今 开3.44
- 成交量 1.31万股
- 最 低 3.3501
- 昨 收 3.37
- 总市值 1485.30万
- 52周最高 8.48
- 市盈率 静 --
- 换手率 0.30%
- 52周最低 1.0266
- 委 比 -50.00%
- 总股本 433.03万
- 历史最高 296.60
- 量 比 0.70
- 振 幅 6.52%
- 历史最低 1.0266
- 每 手 1
- 风险率 0.83%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Cyclerion Therapeutics Q1 EPS $(0.76) Down From $(0.56) YoY
Cyclerion Therapeutics (NASDAQ:CYCN) reported quarterly losses of $(0.76) per share. This is a 35.71 percent decrease over losses of $(0.56) per share from the same period last year.
05-13 05:32
Are UNF, NSA, CYCN, ULYX Obtaining Fair Deals for their Shareholders?
Insiders may stand to receive substantial financial benefits not available to ordinary shareholders. The proposed transactions may contain terms that could limit superior competing offers. S...
04-10 03:30
12 Health Care Stocks Moving In Wednesday's Intraday Session
Gainers Cyclerion Therapeutics (NASDAQ:CYCN) shares rose 307.1% to $6.31 durin...
04-02 01:06
BUZZ-Cyclerion soars on merger deal with Korsana
BUZZ-Cyclerion soars on merger deal with Korsana Updates ** Shares of biotech firm Cyclerion Therapeutics CYCN.O soar nearly threefold to $ 4.83 in premarket trading ** Co says it will merge with private firm Korsana Biosciences and focus on treatments for Alzheimer's , a n eurodegenerative disorder
04-01 21:16
BUZZ-U.S. STOCKS ON THE MOVE-Seagate, nCino, Zymeworks
BUZZ-U.S. STOCKS ON THE MOVE-Seagate, nCino, Zymeworks Workspace search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 April 1 (Reuters) - U.S. stock futures rose on Wednesday, after the indexes
04-01 19:40
Cyclerion Therapeutics shares are trading higher after the company announced it entered into a definitive merger agreement with Korsana Biosciences.
Cyclerion Therapeutics shares are trading higher after the company announced it...
04-01 19:28
BRIEF-Cyclerion Therapeutics And Korsana Biosciences Announce Merger Agreement
BRIEF-Cyclerion Therapeutics And Korsana Biosciences Announce Merger Agreement April 1 (Reuters) - Cyclerion Therapeutics Inc CYCN.O : CYCLERION THERAPEUTICS AND KORSANA BIOSCIENCES ANNOUNCE MERGER AGREEMENT CO AND KORSANA ANNOUNCE DEFINITIVE ALL-STOCK MERGER AGREEMENT KORSANA SECURES PRIVATE INVEST
04-01 19:14
Cyclerion agrees all-stock merger with Korsana, to rename and trade as KRSA
Cyclerion agrees all-stock merger with Korsana, to rename and trade as KRSA Cyclerion entered a definitive all-stock merger agreement with privately held Korsana Biosciences. Combined company plans to operate as Korsana Biosciences, trading on Nasdaq under ticker KRSA. Korsana secured commitments fo
04-01 19:06
Eli Lilly and Co Stock (LLY) Moved Up by 5.46% on Apr 1: Facts Behind the Movement
• Eli Lilly to acquire Centessa Pharmaceuticals for up to $7.8 billion. • Acquisition expands neuroscience portfolio into sleep-wake disorders. • Analysts maintain "Buy" ratings with substantial upside price targets.
04-01 14:15
Cyclerion Therapeutics Announces Progress Toward CYC-126 Phase 2 Proof-of-Concept Study with FDA Feedback and Formation of Clinical Advisory Board
Cyclerion Therapeutics has received positive regulatory feedback from the FDA for its Phase 2 POC study of CYC-126 for treatment-resistant depression (TRD). CYC-126, an anesthetic-based therapy using real-time EEG feedback, aims to address TRD through individualized, precision delivery. The FDA supports the study design, leveraging approved anesthetics, allowing Cyclerion to remain on track to initiate the trial in late 2026. Additionally, the co...
02-17 12:00
